Back to RCUS
MARSHALL WACE, LLP RCUS Position History
Arcus Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$57.2M
Q2 2026
Peak value
$80.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $79K |
| Q1 2025 | $801K |
| Q4 2025 | $43K |
| Q4 2025 | $80.7M |
| Q2 2026 | $2.8M |
| Q2 2026 | $57.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $57.2M | 1.85M | — | — |
| Q2 2026 | $2.8M | 90.1K | — | — |
| Q4 2025 | $80.7M | 3.39M | — | — |
| Q4 2025 | $43K | 1.8K | — | — |
| Q1 2025 | $801K | 102.0K | — | — |
| Q1 2025 | $79K | 10.0K | — | — |
Other funds holding RCUS
$185.9M
$185.9M
$116.9M
$100.3M
$96.7M
$96.7M